mRNA– tag –
-
Machine Learning Accelerates Lipid Nanoparticle (LNP) Design, Dramatically Boosting Efficiency and Speed in Therapeutic Molecule Delivery
Pharmatica International Overview While lipid nanoparticles (LNPs) are crucial for protecting and safely transporting therapeutic molecules like mRNA and siRNA to target cells, their design is inherently complex. Researchers have success... -
CREATE Medicines Expands Targeted In Vivo CAR Platform via Monash University Partnership, Driving Cell-Type-Specific Delivery with Advanced LNP Technology
BioSpace Australia Overview CREATE Medicines has expanded its targeted in vivo CAR platform through a strategic research collaboration and exclusive license agreement with Monash University. This partnership leverages targeted lipid nano... -
Exosome Therapeutics Firm Unveils Advanced Platform, Pipeline Progress Targeting Regenerative Medicine and Enhanced Drug Delivery
Company Disclosures USA Overview An exosome-based therapeutics company has detailed significant pipeline advancements and its cutting-edge technology platform at a recent investor briefing. The presentation particularly emphasized exosom... -
Unlocking Exosome Therapies for Corneal Disorders: Overcoming the Clinical Translation Challenge
Annals of Translational Medicine China Overview A recent review in *Annals of Translational Medicine* underscores the significant hurdles facing exosome-based therapies for corneal disorders, primarily in achieving manufacturing standard... -
iPSC-Derived Microglia-like Cells Reveal Protocol-Specific Transcriptomes and Potent Glioma Phagocytosis, Advancing Brain Tumor Research
bioRxiv USA Overview Human induced pluripotent stem cell (iPSC)-derived microglia-like cells (iMG) are emerging as critical tools for understanding human microglia function and the brain tumor microenvironment. A comprehensive study anal... -
FDA Flags Unapproved Exosome Therapies, Citing Safety Concerns and International Regulatory Gaps
PLANEW Clinic South Korea Overview Exosome therapy is attracting significant attention for its regenerative potential, particularly in skin treatments, yet currently lacks U.S. FDA approval. The FDA has issued public safety warnings agai... -
CRISPR Gene Editing Technology Drives Clinical Adoption: FDA’s First Approval, Casgevy, for Sickle Cell Disease and Beta Thalassemia Accelerates Clinical Translation
Britannica Global Overview CRISPR, a powerful gene-editing tool with high sequence specificity, precisely removes or inserts DNA at specific genomic locations, offering superior efficiency, reliability, and cost-effectiveness over tradit... -
Fujifilm Diosynth Commits $2 Billion to North Carolina Gene Therapy Facility Amid Supply Chain Shifts; India Emerges as Key CDMO Hub
BioSpace Global Overview Fujifilm Diosynth is investing approximately $2 billion in a new gene therapy manufacturing facility in North Carolina, strategically positioning against global supply chain shifts. Catalent, under Novo Holdings,... -
Nanopore-Mediated Assembly Enables Precise and Continuous Synthesis of mRNA-Encapsulated Lipid Nanoparticles, Accelerating COVID-19 Vaccine Development
ACS Nano (ACS Publications) USA Overview This research presents a nanopore-mediated assembly method for the precise and continuous synthesis of mRNA-encapsulated lipid nanoparticles (LNPs), critical for COVID-19 vaccines and other RNA th... -
mRNA Vaccine Patches Demonstrate Enhanced Stability with Polymer Matrix Drying, Paving Way for Cold Chain-Free Distribution
Managed Healthcare Executive USA Overview A study in Advanced Functional Materials indicates that mRNA vaccine nanoparticles remain stable when dried within a polymer matrix for microneedle patches. This breakthrough eliminates the need ...
